AU2001296714A1 - Use of (d-leu2)-deltrophin for treating cytokine mediated hgepatic injury - Google Patents

Use of (d-leu2)-deltrophin for treating cytokine mediated hgepatic injury

Info

Publication number
AU2001296714A1
AU2001296714A1 AU2001296714A AU9671401A AU2001296714A1 AU 2001296714 A1 AU2001296714 A1 AU 2001296714A1 AU 2001296714 A AU2001296714 A AU 2001296714A AU 9671401 A AU9671401 A AU 9671401A AU 2001296714 A1 AU2001296714 A1 AU 2001296714A1
Authority
AU
Australia
Prior art keywords
hgepatic
deltrophin
leu2
injury
cytokine mediated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001296714A
Inventor
Shirish Barve
Paul D. Bishop
Craig J. Mcclain
Peter R. Oeltgen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
University of Kentucky Research Foundation
Original Assignee
Zymogenetics Inc
University of Kentucky Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc, University of Kentucky Research Foundation filed Critical Zymogenetics Inc
Publication of AU2001296714A1 publication Critical patent/AU2001296714A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001296714A 2000-10-10 2001-10-09 Use of (d-leu2)-deltrophin for treating cytokine mediated hgepatic injury Abandoned AU2001296714A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US23899100P 2000-10-10 2000-10-10
US60/238,991 2000-10-10
US09/971,902 US6875742B2 (en) 2000-10-10 2001-10-05 Method for treating cytokine mediated hepatic injury
US09/971,902 2001-10-05
PCT/US2001/031433 WO2002030442A2 (en) 2000-10-10 2001-10-09 Use of [d-leu2]-deltrophin for treating cytokine mediated hgepatic injury

Publications (1)

Publication Number Publication Date
AU2001296714A1 true AU2001296714A1 (en) 2002-04-22

Family

ID=26932168

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001296714A Abandoned AU2001296714A1 (en) 2000-10-10 2001-10-09 Use of (d-leu2)-deltrophin for treating cytokine mediated hgepatic injury

Country Status (3)

Country Link
US (2) US6875742B2 (en)
AU (1) AU2001296714A1 (en)
WO (1) WO2002030442A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875742B2 (en) * 2000-10-10 2005-04-05 Zymogenetics, Inc. Method for treating cytokine mediated hepatic injury
US7705119B1 (en) 2007-04-09 2010-04-27 University Of Kentucky Research Foundation Compositions and methods useful for treating circulatory and hypovolemic shock

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656420A (en) 1995-02-24 1997-08-12 University Of Kentucky Research Foundation Method for employing the delta opioid dadle to extend tissue survival time during ischemia
US6103722A (en) 1997-07-23 2000-08-15 The Medical College Of Wisconsin Research Foundation Inc. Ischemic preconditioning
ATE220330T1 (en) 1998-05-01 2002-07-15 Univ Kentucky Res Found DELTORPHIN FOR THE TREATMENT OF ISCHEMIA
AU751972B2 (en) * 1998-05-01 2002-09-05 University Of Kentucky Research Foundation, The Method for treating cytokine mediated hepatic injury
US6380164B1 (en) * 1999-04-30 2002-04-30 University Of Kentucky Research Foundation Method for treating cytokine mediated hepatic injury
US6875742B2 (en) * 2000-10-10 2005-04-05 Zymogenetics, Inc. Method for treating cytokine mediated hepatic injury

Also Published As

Publication number Publication date
US6875742B2 (en) 2005-04-05
US7335642B2 (en) 2008-02-26
WO2002030442A3 (en) 2002-09-12
WO2002030442A2 (en) 2002-04-18
US20020103124A1 (en) 2002-08-01
US20050164942A1 (en) 2005-07-28

Similar Documents

Publication Publication Date Title
AU2002226069A1 (en) Compositions comprising temozolomide and thalidomide and methods for the treatment of cancer
AU2002224417A1 (en) Methods for treating il-18 mediated disorders
AU2001251136A1 (en) Compositions and methods for promoting wound healing
AU6147401A (en) Compositions and methods for the treatment of cancer
AU2001257069A1 (en) Photostimulaton treatment apparatus and methods for use
AU2001252605A1 (en) Laser treatment apparatus
AU2001233081A1 (en) Composition for treatment of stress
AU2002240401A1 (en) Methods and apparatus for treating hemorrhoids and similar ailments
AU2001273331A1 (en) Methods and apparatus for mechanical treatment of materials such as catalysts
AU2002248269A1 (en) Use of p38 inhibitors for the treatment of inflammation-enhanced cough
AU2001265253A1 (en) Treatment of hiv using hyperthermia
AU2001286983A1 (en) Method of treatment
AU2002226947A1 (en) Bunion treating device
AU2001296714A1 (en) Use of (d-leu2)-deltrophin for treating cytokine mediated hgepatic injury
AU6137801A (en) Method and composition for the treatment of angiogenesis
AU2001232951A1 (en) Combination of temozolomide and pegylated interferon-alpha for treating cancer
AU2000231423A1 (en) Specific therapeutic composition for treating aids
GB0020588D0 (en) Treatment of wounds
AU2002221760A1 (en) Vaccine for treating allergy
AU2002221566A1 (en) Novel benzimidazole derivatives for the treatment of gaba-alpha mediated disorders
PL362896A1 (en) Pyrrole derivates for treating cytokine mediated diseases
AU2002327531A1 (en) Therapeutic compositions and methods for treating viral infection
AU2001253560A1 (en) Methods of treatment
AU2001237029A1 (en) Compositions comprising flavopiridol and their use for hiv therapy
AU2002362224A1 (en) Methods of treating cytokine mediated diseases